Thailand ta amince da rigakafin cutar Covid-19 na Johnson & Johnson. Amfanin wannan rigakafin shine cewa ana buƙatar harbi 1 kawai.
Johnson & Johnson (Janssen) shine masana'anta na uku da suka sami izini daga Hukumar Kula da Abinci da Magunguna ta Thai, in ji Mataimakin Firayim Minista kuma Ministan Lafiya Anutin Charnvirakul. An amince da allurar rigakafin da AstraZeneca da Sinovac Biotech suka yi a baya kuma ana amfani da su a cikin shirin rigakafi na ƙasa.
Ana iya adana rigakafin Janssen a zazzabi na firiji. Har ila yau, tare da rigakafin da aka samar a cikin Netherlands (Leiden), harbi daya ne kawai ake bukata a yi, ba kamar yawancin sauran alluran rigakafi ba.
Amincewa ta uku ta nuna cewa Thailand a buɗe take ga duk masu kera allurar rigakafi kuma tana ɗokin samar da ƙarin zaɓi ga jama'a, in ji Anutin.
Alurar rigakafin Corona daga Johnson & Johnson (Janssen)
Alurar rigakafin corona daga Johnson & Johnson (Janssen) ta ƙunshi harbi ɗaya. Makonni hudu bayan wannan harbin, ana samun cikakkiyar kariya daga cutar corona. Janssen's corona maganin alurar riga kafi ne wanda ya ƙunshi kwayar cutar sanyi mara lahani (adenovirus). An ƙara ɗan ƙaramin lambar kwayoyin halitta kamar yadda yake a cikin coronavirus an ƙara zuwa wannan ƙwayar sanyi. An gyara cutar sanyi ta yadda ba za ta iya karuwa ba kuma baya haifar da rashin lafiya. Yana, duk da haka, yana tabbatar da cewa tsarin rigakafi na jiki yana samar da ƙwayoyin rigakafi da ƙwayoyin T akan furotin mai karu da ke kan coronavirus. Idan jiki ya sake saduwa da kwayar cutar corona daga baya, ana gane kwayar cutar kuma ta zama mara lahani.
Tambayar ita ce ko mutanen da aka yi wa allurar rigakafin Pfizer ko Moderna nan ba da jimawa ba za su kasance cikin haɗarin hana shiga ƙasar, saboda waɗannan 2 ɗin ba su sami izini ba (har yanzu?) Izinin Abinci da Magunguna na Thai.